Practicability of Bivalirudin plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis

Código QR

Practicability of Bivalirudin plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis

A variety of antithrombotic drugs are used during percutaneous coronary interventions (PCIs). We aimed to investigate the practicability of the use of bivalirudin and GPIs in patients receiving PCI. We searched 7 of 629 relevant records from PubMed, the Cochrane Library, EMBASE, and Web of Science f...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Senjie Li, Dongqing Lv, Caihong Liu, Yongping Jia
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/927e121ebd9f4d67bb37804ff7ad5452
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor
por: Ömer Doğan, et al.
Publicado: (2021)

One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock
por: Krzysztof Myrda, et al.
Publicado: (2021)

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.
por: Amir Faour, et al.
Publicado: (2021)

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention
por: Amir Faour, et al.
Publicado: (2021)

Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Jangho Park, et al.
Publicado: (2021)

Impact of the Malnutrition on Mortality in Elderly Patients Undergoing Percutaneous Coronary Intervention
por: Chen L, et al.
Publicado: (2021)

Optimizing glucose control for diabetic patients undergoing percutaneous coronary intervention
por: Haseong Chang, et al.
Publicado: (2021)

Immediate versus Deferred Stenting for Patients Undergoing Primary Percutaneous Coronary Intervention
por: Ahmed Almorsy, et al.
Publicado: (2021)

Prognostic significance of Troponin I in patients undergoing primary percutaneous coronary intervention
por: Pratik Sudhir Sane, DNB, et al.
Publicado: (2021)

IN STENT RESTENOSIS (ISR) IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR CORONARY ARTERY DISEASE (CAD)
por: Waseem Raja, et al.
Publicado: (2020)

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention
por: Johny Nicolas, et al.
Publicado: (2020)

High Incidence of Cataracts in the Follow-Up of Patients Undergoing Percutaneous Coronary Intervention for Chronic Coronary Total Occlusion
por: Ricardo Rivera-López, et al.
Publicado: (2021)

Association between smoking status and outcomes in myocardial infarction patients undergoing percutaneous coronary intervention
por: Ching-Hui Sia, et al.
Publicado: (2021)

Predictors of Adverse Events Among Chronic Total Occlusion Patients Undergoing Successful Percutaneous Coronary Intervention and Medical Therapy
por: Yang L, et al.
Publicado: (2021)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Marek Koziński, et al.
Publicado: (2020)

Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: Implications for primary prevention.
por: Zoya Gurm, et al.
Publicado: (2021)

Improvement of regional myocardial diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention as assessed by strain rate imaging
por: Ch Kapil Karthikeya Reddy, et al.
Publicado: (2021)

Association between inter-leg blood pressure difference and cardiovascular outcome in patients undergoing percutaneous coronary intervention.
por: Inki Moon, et al.
Publicado: (2021)

Comparison between a Bare–Metal Stents and Drug Eluting Stents in patients undergoing Percutaneous Coronary Intervention.
por: Khaled Alsayed
Publicado: (2020)

OUTCOME OF PERCUTANEOUS CORONARY INTERVENTION IN TOTALLY OCCLUDED CORONARY ARTERIES
por: Nisar Ahmed, et al.
Publicado: (2019)

Percutaneous Coronary Intervention for Chronic Total Occlusion
por: Giovanni Maria Vescovo, et al.
Publicado: (2020)

Diagnostic Angiograms and Percutaneous Coronary Interventions in Pregnancy
por: Phyo Htet Khaing, et al.
Publicado: (2020)

Post percutaneous coronary intervention hemoglobin levels predict in-hospital mortality in patients with STEMI treated with primary percutaneous coronary intervention
por: Gönül Zeren, et al.
Publicado: (2021)

Beta-blockers provide a differential survival benefit in patients with coronary artery disease undergoing contemporary post-percutaneous coronary intervention management
por: Pil Hyung Lee, et al.
Publicado: (2020)

The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
por: Lele Cheng, et al.
Publicado: (2021)

Intravascular Ultrasound Guidance Improves the Long-term Prognosis in Patients with Unprotected Left Main Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Jian Tian, et al.
Publicado: (2017)

Percutaneous Coronary Intervention in Elderly Patients with Coronary Chronic Total Occlusions: Current Evidence and Future Perspectives
por: Guo L, et al.
Publicado: (2020)

OUTCOMES OF TRANSRADIAL APPROACH IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
por: Amna Rashdi, et al.
Publicado: (2020)

Percutaneous Coronary Intervention: Developments in the Last 12 Months
por: Rhian E Davies, et al.
Publicado: (2019)

Left main coronary disease percutaneous coronary intervention: The quest to reconcile the inconsistencies
por: Juan F. Iglesias, et al.
Publicado: (2021)

Predictive value of the age, creatinine and ejection fraction score in patients undergoing primary percutaneous coronary intervention with bail-out tirofiban therapy
por: Altuğ Ösken, et al.
Publicado: (2021)

Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
por: Abdelmoniem Moustafa, et al.
Publicado: (2020)

Role of Intravascular Ultrasound in Guiding Complex Percutaneous Coronary Interventions
por: Brandon Quintana, et al.
Publicado: (2020)

The Role of Hemodynamic Support in High-risk Percutaneous Coronary Intervention
por: Charles Simonton, et al.
Publicado: (2020)

Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
por: Despoina-Rafailia Benetou, et al.
Publicado: (2021)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Huilin Hu, et al.
Publicado: (2021)

Pregnancy-specific glycoproteins bind integrin αIIbβ3 and inhibit the platelet-fibrinogen interaction.
por: Daniel K Shanley, et al.
Publicado: (2013)

New stent design for use in small coronary arteries during percutaneous coronary intervention
por: Juan F Granada, et al.
Publicado: (2010)

Impact of coronary dominance on in-hospital outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.
por: Toshiki Kuno, et al.
Publicado: (2013)

The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis.
por: Christopher N Floyd, et al.
Publicado: (2014)